{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,13]],"date-time":"2026-09-13T00:40:14Z","timestamp":1789260014217,"version":"build-2803163510"},"reference-count":18,"publisher":"American Society of Hematology","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Blood"],"published-print":{"date-parts":[[2019,8,29]]},"DOI":"10.1182\/blood.2019000258","type":"journal-article","created":{"date-parts":[[2019,7,12]],"date-time":"2019-07-12T20:25:45Z","timestamp":1562963145000},"page":"761-764","source":"Crossref","is-referenced-by-count":126,"title":["Early progression after bendamustine-rituximab is associated with high risk of transformation in advanced stage follicular lymphoma"],"prefix":"10.1182","volume":"134","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0662-6480","authenticated-orcid":false,"given":"Ciara L.","family":"Freeman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0287-7124","authenticated-orcid":false,"given":"Robert","family":"Kridel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alden A.","family":"Moccia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerry J.","family":"Savage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4625-3009","authenticated-orcid":false,"given":"Diego R.","family":"Villa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David W.","family":"Scott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4727-1425","authenticated-orcid":false,"given":"Alina S.","family":"Gerrie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Ferguson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fergus","family":"Cafferty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graham W.","family":"Slack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9364-9391","authenticated-orcid":false,"given":"Pedro","family":"Farinha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Skinnider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph M.","family":"Connors","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurie H.","family":"Sehn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2019,7,12]]},"reference":[{"key":"2019082914252090000_134.9.761.1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-11-531327"},{"key":"2019082914252090000_134.9.761.2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)61763-2"},{"key":"2019082914252090000_134.9.761.3","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2014.59.7534"},{"issue":"suppl 1","key":"2019082914252090000_134.9.761.4","first-page":"1490","article-title":"Early disease progression predicts poorer survival in patients with follicular lymphoma (FL) in the GALLIUM Study","volume":"130","author":"Launonen","year":"2017","journal-title":"Blood"},{"issue":"6","key":"2019082914252090000_134.9.761.5","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.3324\/haematol.2018.209015","article-title":"Association of early disease progression and very poor survival in the GALLIUM study in follicular lymphoma: benefit of obinutuzumab in reducing the rate of early progression","volume":"104","author":"Seymour","year":"2018","journal-title":"Haematologica"},{"issue":"33","key":"2019082914252090000_134.9.761.6","doi-asserted-by":"crossref","first-page":"JCO1800262","DOI":"10.1200\/JCO.18.00262","article-title":"Chemotherapy-free initial treatment of advanced indolent lymphoma has durable effect with low toxicity: results from two Nordic Lymphoma Group Trials with more than 10 years of follow-up","volume":"36","author":"Lockmer","year":"2018","journal-title":"J Clin Oncol"},{"key":"2019082914252090000_134.9.761.7","doi-asserted-by":"publisher","DOI":"10.3109\/10428194.2014.885513"},{"key":"2019082914252090000_134.9.761.8","unstructured":"Swerdlow SHCE , Harris NL , Jaffe ES , Pileri SA , Stein H , Thiele J . WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Revised Fourth Edition. Geneva: World Health Organization; 2016."},{"key":"2019082914252090000_134.9.761.9","doi-asserted-by":"publisher","DOI":"10.2307\/2281868"},{"key":"2019082914252090000_134.9.761.10","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.16.0283"},{"key":"2019082914252090000_134.9.761.11","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.48.3990"},{"issue":"11","key":"2019082914252090000_134.9.761.12","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1002\/ajh.24492","article-title":"Early event status informs subsequent outcome in newly diagnosed follicular lymphoma","volume":"91","author":"Maurer","year":"2016","journal-title":"Am J Hematol"},{"key":"2019082914252090000_134.9.761.13","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-99-116686"},{"issue":"12","key":"2019082914252090000_134.9.761.14","doi-asserted-by":"crossref","first-page":"e1002197","DOI":"10.1371\/journal.pmed.1002197","article-title":"Histological transformation and progression in follicular lymphoma: a clonal evolution study","volume":"13","author":"Kridel","year":"2016","journal-title":"PLoS Med"},{"key":"2019082914252090000_134.9.761.15","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aai8545"},{"key":"2019082914252090000_134.9.761.16","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-05-717355"},{"issue":"4","key":"2019082914252090000_134.9.761.17","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S1470-2045(18)30102-5","article-title":"A gene-expression profiling score for prediction of outcome in patients with follicular lymphoma: a retrospective training and validation analysis in three international cohorts","volume":"19","author":"Huet","year":"2018","journal-title":"Lancet Oncol"},{"issue":"6","key":"2019082914252090000_134.9.761.18","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/j.bbmt.2017.12.771","article-title":"Autologous transplantation in follicular lymphoma with early therapy failure: a National LymphoCare Study and Center for International Blood and Marrow Transplant Research Analysis","volume":"24","author":"Casulo","year":"2018","journal-title":"Biol Blood Marrow Transplant"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1182\/blood.2019000258","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,29]],"date-time":"2019-08-29T17:25:58Z","timestamp":1567099558000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.bloodjournal.org\/lookup\/doi\/10.1182\/blood.2019000258"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,12]]},"references-count":18,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2019,8,29]]},"published-print":{"date-parts":[[2019,8,29]]}},"alternative-id":["10.1182\/blood.2019000258"],"URL":"https:\/\/doi.org\/10.1182\/blood.2019000258","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,12]]}}}